1 | 0 381 494 73 | | | | | | | 9 | 0.91% |
2 | 49 0 381 494 | | | | | | | 8 | 0.80% |
3 | 0 381 494 7330 | | | | | | | 6 | 0.60% |
4 | 494 7330 fax 49 | | | | | | | 5 | 0.50% |
5 | 381 494 7330 fax | | | | | | | 5 | 0.50% |
6 | phone 49 0 381 | | | | | | | 5 | 0.50% |
7 | at the same time | | | | | | | 4 | 0.40% |
8 | 7330 fax 49 0 | | | | | | | 4 | 0.40% |
9 | fax 49 0 381 | | | | | | | 4 | 0.40% |
10 | 381 494 73 74 | | | | | | | 3 | 0.30% |
11 | europäischen fonds für regionale | | | | | | | 2 | 0.20% |
12 | with just one dialyzer | | | | | | | 2 | 0.20% |
13 | europäischen union aus dem | | | | | | | 2 | 0.20% |
14 | one enhanced blood flow | | | | | | | 2 | 0.20% |
15 | wirdwurde kofinanziert von der | | | | | | | 2 | 0.20% |
16 | in critical care our | | | | | | | 2 | 0.20% |
17 | intensive care units and | | | | | | | 2 | 0.20% |
18 | achieve a sustainable reduction | | | | | | | 2 | 0.20% |
19 | innovation and gradual improvements | | | | | | | 2 | 0.20% |
20 | volume heat loss and | | | | | | | 2 | 0.20% |
21 | using just one enhanced | | | | | | | 2 | 0.20% |
22 | components using just one | | | | | | | 2 | 0.20% |
23 | care units and while | | | | | | | 2 | 0.20% |
24 | needed volume heat loss | | | | | | | 2 | 0.20% |
25 | just one dialyzer the | | | | | | | 2 | 0.20% |
26 | using just one dialyzer | | | | | | | 2 | 0.20% |
27 | heat loss and minimizing | | | | | | | 2 | 0.20% |
28 | to achieve a sustainable | | | | | | | 2 | 0.20% |
29 | loss and minimizing the | | | | | | | 2 | 0.20% |
30 | kidney and liver support | | | | | | | 2 | 0.20% |
31 | with kidney and liver | | | | | | | 2 | 0.20% |
32 | surface contact on the | | | | | | | 2 | 0.20% |
33 | of multi organ failure | | | | | | | 2 | 0.20% |
34 | blood side to achieve | | | | | | | 2 | 0.20% |
35 | side to achieve a | | | | | | | 2 | 0.20% |
36 | the same time – | | | | | | | 2 | 0.20% |
37 | just one enhanced blood | | | | | | | 2 | 0.20% |
38 | experienced incremental innovation and | | | | | | | 2 | 0.20% |
39 | morbidity and mortality in | | | | | | | 2 | 0.20% |
40 | the high levels of | | | | | | | 2 | 0.20% |